Eng Lo - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Mechanisms of Cell Death in Stroke and Trauma

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Shindo A, Takase H, Hamanaka G, Chung KK, Mandeville ET, Egawa N, Maki T, Borlongan M, Takahashi R, Lok J, Tomimoto H, Lo EH, Arai K. Biphasic roles of pentraxin 3 in cerebrovascular function after white matter stroke. Cns Neuroscience & Therapeutics. PMID 33314664 DOI: 10.1111/cns.13510  0.318
2020 Deng W, Mandeville E, Terasaki Y, Li W, Holder J, Chuang AT, Ning M, Arai K, Lo EH, Xing C. Transcriptomic characterization of microglia activation in a rat model of ischemic stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 40: S34-S48. PMID 33208001 DOI: 10.1177/0271678X20932870  0.302
2019 Bonsack B, Borlongan MC, Lo EH, Arai K. Brief overview: Protective roles of astrocyte-derived pentraxin-3 in blood-brain barrier integrity. Brain Circulation. 5: 145-149. PMID 31620663 DOI: 10.4103/bc.bc_37_19  0.312
2019 Shehadah A, Matheson R, Chida K, Selim M, Lo E. Abstract TP316: Histone Deacetylase 3 as a Novel Therapeutic Target for Ischemic Stroke Stroke. 50. DOI: 10.1161/Str.50.Suppl_1.Tp316  0.352
2018 Jiang Y, Liu N, Wang Q, Yu Z, Lin L, Yuan J, Guo S, Ahn BJ, Wang XJ, Li X, Lo EH, Sun X, Wang X. Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice. Stroke. 49: 3039-3049. PMID 30571410 DOI: 10.1161/STROKEAHA.118.022119  0.306
2018 Yu Z, Cheng C, Liu Y, Liu N, Lo EH, Wang X. Neuroglobin promotes neurogenesis through Wnt signaling pathway. Cell Death & Disease. 9: 945. PMID 30237546 DOI: 10.1038/s41419-018-1007-x  0.305
2018 Chan SJ, Zhao H, Hayakawa K, Chai C, Tan CT, Huang J, Tao R, Hamanaka G, Arumugam TV, Lo EH, Yu VCK, Wong PH. Modulator of apoptosis-1 is a potential therapeutic target in acute ischemic injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18794839. PMID 30132384 DOI: 10.1177/0271678X18794839  0.318
2018 Bustamante A, Ning M, García-Berrocoso T, Penalba A, Boada C, Simats A, Pagola J, Ribó M, Molina C, Lo E, Montaner J. Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke. Neurology. PMID 29444972 DOI: 10.1212/Wnl.0000000000005162  0.353
2017 Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP, Carmichael ST, Cho S, Cipolla MJ, Corbett D, Corriveau RA, Cramer SC, Ferguson AR, Finklestein SP, Ford BD, ... ... Lo EH, et al. Translational Stroke Research: Vision and Opportunities. Stroke. PMID 28751554 DOI: 10.1161/Strokeaha.117.017112  0.329
2017 Fan X, Jiang Y, Yu Z, Liu Q, Guo S, Sun X, van Leyen K, Ning M, Gao X, Lo EH, Wang X. Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats. Translational Stroke Research. PMID 28580536 DOI: 10.1007/s12975-017-0542-6  0.309
2017 Shindo A, Maki T, Egawa N, Liang A, Itoh K, Lo E, Arai K, Tomimoto H. Pentraxin 3 supports blood-brain barrier integrity after ischemic stroke Journal of the Neurological Sciences. 381: 995. DOI: 10.1016/J.Jns.2017.08.2807  0.384
2016 Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, Durand A, El Amki M, Fatar M, Garcia-Yébenes I, Gauberti M, Grudzenski S, Lizasoain I, Lo E, Macrez R, et al. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis. Stroke; a Journal of Cerebral Circulation. PMID 27032444 DOI: 10.1161/Strokeaha.116.012238  0.378
2014 Fan X, Jiang Y, Yu Z, Yuan J, Sun X, Xiang S, Lo EH, Wang X. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes. Advances in Pharmacology (San Diego, Calif.). 71: 391-410. PMID 25307224 DOI: 10.1016/bs.apha.2014.06.007  0.301
2013 Hayakawa K, Pham LD, Arai K, Lo EH. High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochirurgica. Supplement. 118: 31-8. PMID 23564100 DOI: 10.1007/978-3-7091-1434-6_5  0.303
2013 Yigitkanli K, Pekcec A, Karatas H, Pallast S, Mandeville E, Joshi N, Smirnova N, Gazaryan I, Ratan RR, Witztum JL, Montaner J, Holman TR, Lo EH, van Leyen K. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Annals of Neurology. 73: 129-35. PMID 23192915 DOI: 10.1002/Ana.23734  0.328
2013 Pekcec A, Yigitkanli K, Jung JE, Pallast S, Xing C, Antipenko A, Minchenko M, Nikolov DB, Holman TR, Lo EH, Van Leyen K. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling Faseb Journal. 27: 437-445. PMID 23070608 DOI: 10.1096/fj.12-20689  0.319
2012 Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. 7: 378-85. PMID 22712739 DOI: 10.1111/j.1747-4949.2012.00839.x  0.304
2012 Lopez MF, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Gvozdyak O, Chou S, Lo E, Buonanno F, Ning M. Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm. Proteomics. Clinical Applications. 6: 190-200. PMID 22532455 DOI: 10.1002/Prca.201100041  0.355
2012 Hayakawa K, Pham LD, Katusic ZS, Arai K, Lo EH. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proceedings of the National Academy of Sciences of the United States of America. 109: 7505-10. PMID 22529378 DOI: 10.1073/pnas.1121146109  0.319
2011 Arai K, Lok J, Guo S, Hayakawa K, Xing C, Lo EH. Cellular mechanisms of neurovascular damage and repair after stroke. Journal of Child Neurology. 26: 1193-8. PMID 21628695 DOI: 10.1177/0883073811408610  0.316
2010 Ning M, Sarracino DA, Buonanno FS, Krastins B, Chou S, McMullin D, Wang X, Lopez M, Lo EH. Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Translational Stroke Research. 1: 268-75. PMID 22140417 DOI: 10.1007/s12975-010-0047-z  0.31
2010 Arai K, Lo EH. Oligovascular signaling in white matter stroke. Biological & Pharmaceutical Bulletin. 32: 1639-44. PMID 19801821 DOI: 10.1248/bpb.32.1639  0.303
2009 Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, Lo EH. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. Bmc Neuroscience. 10: 79. PMID 19604385 DOI: 10.1186/1471-2202-10-79  0.304
2009 Navaratna D, Guo S, Arai K, Lo EH. Mechanisms and targets for angiogenic therapy after stroke. Cell Adhesion & Migration. 3: 216-23. PMID 19363301 DOI: 10.4161/cam.3.2.8396  0.319
2008 Wang X, Rosell A, Lo EH. Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy. Cns & Neurological Disorders Drug Targets. 7: 235-42. PMID 18673208 DOI: 10.2174/187152708784936635  0.308
2008 Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nature Medicine. 14: 497-500. PMID 18463660 DOI: 10.1038/nm1735  0.31
2008 Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E, Milne GL, Hubbard J, Lee H, Stevenson E, Lederer M, Furie KL. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke; a Journal of Cerebral Circulation. 39: 100-4. PMID 18063832 DOI: 10.1161/Strokeaha.107.488189  0.31
2005 Singhal AB, Lo EH, Dalkara T, Moskowitz MA. Advances in stroke neuroprotection: hyperoxia and beyond. Neuroimaging Clinics of North America. 15: 697-720, xii-xiii. PMID 16360598 DOI: 10.1016/j.nic.2005.08.014  0.304
2005 Lee SR, Wang X, Tsuji K, Lo EH. Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurological Research. 26: 854-61. PMID 15727269 DOI: 10.1179/016164104X3806  0.307
1996 Yelnik A, Bonan I, Debray M, Lo E, Gelbert F, Bussel B. Changes in the Execution of a Complex Manual Task After Ipsilateral Ischemic Cerebral Hemispheric Stroke Archives of Physical Medicine and Rehabilitation. 77: 806-810. PMID 8702376 DOI: 10.1016/S0003-9993(96)90261-0  0.342
Show low-probability matches.